BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 29929470)

  • 41. Assessment of longitudinal serum neutrophil extracellular trap-inducing activity in anti-neutrophil cytoplasmic antibody-associated vasculitis and glomerulonephritis in a prospective cohort using a novel bio-impedance technique.
    Aendekerk JP; Ysermans R; Busch MH; Theunissen ROMFIH; Bijnens N; Potjewijd J; Damoiseaux JGMC; Reutelingsperger CP; van Paassen P
    Kidney Int; 2023 Jul; 104(1):151-162. PubMed ID: 37088424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute tubulointerstitial nephritis associated with antineutrophil cytoplasmic antibody following cimetidine treatment: a case report.
    Morimoto K; Kanzaki G; Niikura T; Koike K; Matsuo N; Maruyama Y; Tsuboi N; Yokoo T
    BMC Nephrol; 2021 Aug; 22(1):294. PubMed ID: 34461843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.
    Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA
    Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Pepper RJ; Draibe JB; Caplin B; Fervenza FC; Hoffman GS; Kallenberg CG; Langford CA; Monach PA; Seo P; Spiera R; William St Clair E; Tchao NK; Stone JH; Specks U; Merkel PA; Salama AD;
    Arthritis Rheumatol; 2017 Jan; 69(1):185-193. PubMed ID: 27428710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The significances of peripheral neutrophils CD(55) and myeloperoxidase expression in patients with myeloperoxidase-specific anti-neutrophil cytoplasmic antibody associated vasculitis].
    Zhou XL; Zheng MJ; Shuai ZW; Zhang L; Zhang MM; Chen SY
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):427-432. PubMed ID: 28592042
    [No Abstract]   [Full Text] [Related]  

  • 46. Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Compared to Systemic Lupus Erythematosus.
    van Dam LS; Kraaij T; Kamerling SWA; Bakker JA; Scherer UH; Rabelink TJ; van Kooten C; Teng YKO
    Arthritis Rheumatol; 2019 Dec; 71(12):2047-2058. PubMed ID: 31313503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunohistochemical detection of citrullinated histone H3-positive neutrophils is useful for identifying active glomerular and interstitial lesions in antineutrophil cytoplasmic antibody-associated vasculitis.
    Kimura H; Mii A; Shoji J; Arakawa Y; Shimizu A
    Histopathology; 2021 Mar; 78(4):520-531. PubMed ID: 32956514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody.
    Land J; Rutgers A; Kallenberg CG
    Nephrol Dial Transplant; 2014 Apr; 29(4):739-45. PubMed ID: 24398891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Shuai ZW; Lv YF; Zhang MM; Hu ZY
    Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proposal of anti-moesin as a novel biomarker for ANCA-associated vasculitis.
    Suzuki K; Suzuki K; Nagao T; Nakayama T
    Clin Exp Nephrol; 2013 Oct; 17(5):638-641. PubMed ID: 24072414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis.
    Ueda Y; Nakazawa D; Nishio S; Shiratori-Aso S; Kudo T; Miyoshi-Harashima A; Watanabe-Kusunoki K; Hattanda F; Iwasaki S; Tsuji T; Tomaru U; Aratani Y; Yamamoto M; Ishizu A; Atsumi T
    Kidney Int; 2024 Jun; 105(6):1291-1305. PubMed ID: 38537677
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remission of Granulomatosis with Polyangiitis Only After Resection of a Pulmonary Nodule.
    Kanda R; Nakano K; Nawata A; Iwata S; Nakayamada S; Tanaka Y
    Intern Med; 2022; 61(18):2803-2808. PubMed ID: 36104178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis.
    Arnold S; Kitching AR; Witko-Sarsat V; Wiech T; Specks U; Klapa S; Comdühr S; Stähle A; Müller A; Lamprecht P
    Lancet Rheumatol; 2024 May; 6(5):e300-e313. PubMed ID: 38574743
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
    Holding S; Fisher VJ; Abuzakouk M
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
    Lin W; Chen M; Zhao MH
    Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report.
    Li XL; Xu PC; Chen T; Yan TK; Jiang JQ; Jia JY; Wei L; Shang WY; Hu SY
    Medicine (Baltimore); 2017 Dec; 96(51):e9128. PubMed ID: 29390440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T
    Schreiber A; Rousselle A; Klocke J; Bachmann S; Popovic S; Bontscho J; Schmidt-Ott KM; Siffrin V; Jerke U; Ashraf MI; Panzer U; Kettritz R
    J Am Soc Nephrol; 2020 Jul; 31(7):1569-1584. PubMed ID: 32487561
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pathophysiology and Laboratory Findings in Patients with ANCA-Associated Vasculitis].
    Wada T
    Rinsho Byori; 2015 Oct; 63(10):1213-9. PubMed ID: 26897859
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV).
    Manojlovic M; Juto A; Jonasdottir A; Colic J; Vojinovic J; Nordin A; Bruchfeld A; Gunnarsson I; Mobarrez F; Antovic A
    J Mol Med (Berl); 2020 Sep; 98(9):1279-1286. PubMed ID: 32734361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity.
    Sangaletti S; Tripodo C; Chiodoni C; Guarnotta C; Cappetti B; Casalini P; Piconese S; Parenza M; Guiducci C; Vitali C; Colombo MP
    Blood; 2012 Oct; 120(15):3007-18. PubMed ID: 22932797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.